// App-Quantinova.ai

P5.093 : The synergy between brain amyloidosis and hypometabolism on cognitive decline in humans and transgenic amyloid rats (P5.093)

Researchers

Presenter

  • Tharick A. Pascoal

Principal Investigators

  • Sulantha Mathotaarachchi

  • Serge Gauthier

  • Pedro Rosa Neto

Medical Centers

  • Douglas Hospital Verdun QC Canada

  • Montreal University, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved